J Mattern
Impact in
Papers in
- Oncology 86
- Drug Transport and Resistance Mechanisms 41
- Lung Cancer Research Studies 23
- Cancer Cells and Metastasis 19
-
- Cancer therapeutics and mechanisms 21
- Angiogenesis and VEGF in Cancer 19
- Co-authors
- M Volm (104 shared papers)Reet Koomägi (29 shared papers)Thomas Efferth (19 shared papers)Ingrid Herr (11 shared papers)K. Wayss (33 shared papers)G. Stammler (10 shared papers)Bernd Groner (1 shared paper)Winfried S. Wels (1 shared paper)
In The Last Decade
J Mattern
131 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 93
- Oncology 1.4k
- Genetics 263
- Cancer Research 239
- Radiology, Nuclear Medicine and Imaging 358
- Molecular Biology 1k
Countries citing papers authored by J Mattern
This map shows the geographic impact of J Mattern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Mattern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Mattern more than expected).
Fields of papers citing papers by J Mattern
This network shows the impact of papers produced by J Mattern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Mattern. The network helps show where J Mattern may publish in the future.
Co-authors
The 25 scholars most cited alongside J Mattern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 354 | |
| 2 | 1999 | 324 | |
| 3 | 1996 | 277 | |
| 4 | 2008 | 204 | |
| 5 | 1994 | 179 | |
| 6 | 1989 | 119 | |
| 7 | 2013 | 108 | |
| 8 | 1997 | 89 | |
| 9 | 1993 | 86 | |
| 10 | 1997 | 69 | |
| 11 | 1991 | 66 | |
| 12 | 1995 | 66 | |
| 13 | Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. | 2000 | 62 |
| 14 | 2002 | 59 | |
| 15 | Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. | 1997 | 48 |
| 16 | 2005 | 43 | |
| 17 | 2008 | 43 | |
| 18 | 2016 | 43 | |
| 19 | Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. | 1997 | 42 |
| 20 | PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis. | 1999 | 42 |
About J Mattern
J Mattern is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Toxicology and Cancer Research, having authored 136 papers that have together received 3.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (41 papers), Lung Cancer Research Studies (23 papers), Cancer therapeutics and mechanisms (21 papers), Cancer Cells and Metastasis (19 papers), Angiogenesis and VEGF in Cancer (19 papers), Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Bioactive Compounds and Antitumor Agents (8 papers). The work is most often cited by research in Oncology (1.4k citations), Genetics (263 citations), Cancer Research (239 citations), Radiology, Nuclear Medicine and Imaging (358 citations) and Molecular Biology (1k citations). J Mattern has collaborated with scholars based in Germany, Hungary and Estonia. Frequent co-authors include M Volm, Reet Koomägi, Thomas Efferth, Ingrid Herr, K. Wayss, G. Stammler, Bernd Groner, Winfried S. Wels, Dirk R. Moritz and M. Kaufmann. Their work appears in journals such as International Journal of Oncology, British Journal of Cancer, Oncology Reports, Archives of Gynecology and Obstetrics and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.